Azeliragon ameliorates Alzheimer’s disease via the Janus tyrosine kinase and signal transducer and activator of transcription signaling pathway. Clinics [Internet]. 2021 Nov. 9 [cited 2024 May 3];76:e2348. Available from: https://www.revistas.usp.br/clinics/article/view/192073